SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-044891
Filing Date
2023-12-14
Accepted
2023-12-14 17:00:35
Documents
23
Period of Report
2023-12-14
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 42547
2 ex99-1.htm EX-99.1 146710
3 ex99-2.htm EX-99.2 310245
4 ex99-2_001.jpg GRAPHIC 13962
5 ex99-2_002.jpg GRAPHIC 6030
6 ex99-2_003.jpg GRAPHIC 11782
7 ex99-2_004.jpg GRAPHIC 13607
8 ex99-2_005.jpg GRAPHIC 19524
9 ex99-2_006.jpg GRAPHIC 14647
10 ex99-2_007.jpg GRAPHIC 12348
11 ex99-2_008.jpg GRAPHIC 15368
  Complete submission text file 0001493152-23-044891.txt   943385

Data Files

Seq Description Document Type Size
12 XBRL SCHEMA FILE bct-20231214.xsd EX-101.SCH 3744
13 XBRL DEFINITION FILE bct-20231214_def.xml EX-101.DEF 26582
14 XBRL LABEL FILE bct-20231214_lab.xml EX-101.LAB 36635
15 XBRL PRESENTATION FILE bct-20231214_pre.xml EX-101.PRE 25206
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5274
Mailing Address 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR WEST VANCOUVER A1 V7T 2X1
Business Address 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR WEST VANCOUVER A1 V7T 2X1 (604) 921-1810
BriaCell Therapeutics Corp. (Filer) CIK: 0001610820 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 001-40101 | Film No.: 231487791
SIC: 2834 Pharmaceutical Preparations